BIS Certification
CDSCO
PESO
CPCB
LMPC
WPC Approval
Global Approvals
TEC
ARAI
BEE
ISO Certification
DGCA Certification
NOC For Steel
APEDA Registration
Business Registration
FSSAI Mark Certification
 (32).jpg)
Legal Services
Trademark Registration
Copyright Registration
Patent Registration
- CDSCO is India’s central drug regulatory authority that approves new drugs, vaccines, r-DNA products, blood products, and other regulated pharmaceutical products.
- The CDSCO approved drugs list helps manufacturers, importers, distributors, healthcare professionals, and patients verify whether a drug has proper approval in India.
- The official CDSCO website publishes year-wise lists of newly approved drugs, including drug name, indication, and approval date.
- CDSCO also maintains separate approval lists for Fixed Dose Combinations, Subsequent New Drugs, clinical trial approvals, vaccines, and other product categories.
- Selling, importing, or marketing a drug without proper approval can create serious compliance, legal, and business risks.
Introduction | CDSCO approved drugs
The pharmaceutical industry in India is highly regulated because medicines directly affect public health and safety. Before a new drug is manufactured, imported, sold, or marketed in India, it must meet the required standards and approval process under the drug regulatory system. This is where CDSCO plays an important role.
The List of Approved Drugs by CDSCO in India helps businesses and professionals check whether a drug has received official approval from the Indian drug authority. This list is important for pharmaceutical companies, importers, exporters, distributors, hospitals, doctors, and regulatory consultants.
CDSCO approval is not only a legal requirement but also a mark of safety, quality, and regulatory acceptance. Without proper approval, a company may face product rejection, legal notices, market restrictions, or delay in business operations.
What is the CDSCO?
The CDSCO is an officially maintained list of drugs that have been approved by the CDSCO for manufacturing, importing, use or marketing in India. The list normally contains information like the drug name, indication, dosage form, and approval date and possibly applicant/firm name depending upon the product category.
CDSCO maintains separate lists for each type of product category that requires approval by the CDSCO. Such categories can include New Drugs, FDCs, Vaccines, r-DNA derived products, Blood Products, Veterinary Products, and Clinical Trial Approval. Official CDSCO approval lists for New Drug Approvals include Year-wise lists of Approved New Drugs in the following years 2026,2025,2024,2023,and previous years.
Key Points
- It is an official reference list for approved drugs in India.
- It helps verify whether a drug has legal approval.
- It includes new drugs and other regulated pharmaceutical products.
- It supports transparency in the pharmaceutical approval system.
- It is useful for manufacturers, importers, healthcare professionals, and consultants.
Why is the CDSCO Important?
It becomes very essential for the CDSCO as it ensures that the medicines present in the Indian market have been subjected to the necessary regulations.
In case of the pharmaceutical industry, this list becomes helpful for planning, marketing, approval of importing medicines, manufacturing, and marketing approvals. On the other hand, from the healthcare professionals’ point of view, this list ensures that the necessary regulation process has been completed.
Key Points
- It confirms legal approval status.
- It helps avoid regulatory penalties.
- It supports safe medicine availability.
- It helps pharma companies plan product launches.
- It builds trust among doctors, hospitals, distributors, and patients.
Types of Drugs and Products
CDSCO approval is not limited to only one type of medicine. It covers several regulated pharmaceutical and healthcare product categories. Each product category may require a different application route, documentation, evaluation, and approval process.
Important Categories
- New drugs
- Fixed Dose Combinations
- Subsequent New Drugs
- Vaccines
- r-DNA products
- Blood products
- Biological products
- Imported drugs
- Investigational drugs for clinical trials
- Veterinary drug products
- Certain medical and diagnostic products under applicable rules
The CDSCO approval page also includes categories such as CT approvals, FDC and Subsequent New Drugs, approved new drugs, vaccine data, and veterinary marketing authorization.
Importance and Benefits
| Importance / Benefit | Explanation |
| Legal Compliance | Helps businesses confirm whether the drug is approved as per Indian drug regulations. |
| Market Entry Support | Approved drugs can be legally manufactured, imported, distributed, or marketed as per approval conditions. |
| Patient Safety | Approval helps ensure that drugs are reviewed before reaching patients. |
| Business Credibility | Companies with approved products gain better trust in the pharmaceutical market. |
| Reduced Risk | Proper approval reduces the risk of product seizure, notice, rejection, or penalty. |
| Import and Export Support | Approval documents help in regulatory verification for importers and exporters. |
| Transparency | The published list helps businesses and professionals verify drug approval status. |
| Product Planning | Pharma companies can study approved molecules and plan new product development. |
| Doctor and Hospital Confidence | Healthcare professionals can rely on approved drugs for treatment decisions. |
| Regulatory Record | The list acts as an official reference for future compliance checks. |
CDSCO Process in India
The CDSCO process depends on the type of drug, category, risk, dosage form, indication, and whether it is manufactured in India or imported. However, the general process includes the following steps.
Step 1: Product Classification
The first step is to identify the correct category of the product. A drug may fall under a new drug, biological product, vaccine, FDC, SND, imported drug, or clinical trial product category. Wrong classification can lead to rejection or delay.
Step 2: Regulatory Requirement Check
After classification, the applicant must check which approval, form, license, or permission is required. Different products may require different rules, technical data, clinical data, safety information, and government fees.
Step 3: Document Preparation
Documentation is the most important part of the approval process. Common documents may include company details, product composition, manufacturing license, test reports, stability data, safety data, clinical trial data, label details, product monograph, free sale certificate, power of attorney, and authorization letter.
Step 4: Online Application Submission
CDSCO applications are generally submitted through official online portals such as SUGAM or other applicable systems. The application must be filled carefully with correct product, applicant, manufacturer, and technical details.
Step 5: Technical Review by Authority
CDSCO reviews the submitted application and documents. The authority may check product safety, efficacy, quality, labeling, clinical evidence, test data, and manufacturing information.
Step 6: Query or Clarification
If any information is missing or unclear, CDSCO may raise a query. The applicant must respond correctly with supporting documents. Delay in query response can delay approval.
Step 7: Approval or Permission
After successful review, CDSCO grants approval, permission, license, or registration based on the product category. The drug may then appear in the relevant approved drug list if applicable.
Step 8: Post-Approval Compliance
Approval is not the end of compliance. The company must follow labeling rules, pharmacovigilance requirements, quality standards, manufacturing conditions, and renewal or update requirements.
Documents Required
The exact document list depends on the drug category. However, common documents may include:
- Company registration certificate
- Manufacturing license or import license details
- Drug master file
- Product composition details
- Product specification
- Certificate of analysis
- Stability data
- Safety and efficacy data
- Clinical trial data, if applicable
- Label and package insert
- Free Sale Certificate, if imported
- Power of Attorney, if applicable
- GMP certificate
- Site master file
- Test reports
- Undertaking and declarations
- Government fee proof
- Authorization letter
Challenges of Getting CDSCO Without a Consultant
Acquiring CDSCO without assistance from experts is hard as it demands right categorization, technical knowledge, proper documentation, and proper communication with regulatory bodies. The error in any step in the procedure can cause delays, rejection, or questioning.
Firms find it hard as they lack knowledge about the approval path, relevant forms, necessary documentation, and technical details. This makes things even harder in case of new, imported, or fixed dose combination drugs and biologicals.
Common Challenges
- Wrong product classification
- Selection of incorrect application form
- Missing technical documents
- Incomplete safety or efficacy data
- Incorrect labeling details
- Delay in query response
- Lack of understanding of CDSCO portal process
- Confusion between state license and central approval
- Difficulty in preparing regulatory dossiers
- Risk of rejection due to documentation mistakes
Common Mistakes in Application
Many applications get delayed because of avoidable errors. Companies should avoid submitting incomplete or incorrect applications.
Key Mistakes to Avoid
- Submitting unclear product composition
- Using outdated documents
- Not attaching valid test reports
- Giving incorrect manufacturer details
- Missing authorization letters
- Not checking whether clinical data is required
- Submitting labels that do not match regulatory requirements
- Not responding to CDSCO queries on time
- Applying under the wrong product category
- Assuming approval is not required without proper legal verification
How to Check the List of Approved Drugs
Businesses can check the approved drugs list through the official CDSCO website and CDSCO online systems. The CDSCO website publishes year-wise lists of new drugs approved in India and separate lists for FDC and Subsequent New Drugs.
Simple Checking Process
- Visit the official CDSCO website.
- Go to the approval or approved drugs section.
- Select the relevant category such as new drugs, FDC, SND, vaccines, or clinical trial approvals.
- Open the latest year-wise list.
- Search for the drug name, composition, or approval date.
- Cross-check indication, dosage form, and approval details.
- For business use, consult a regulatory expert before taking action.
Why Choose Diligence Certification ?
Diligence Certification helps pharmaceutical companies, importers, and healthcare businesses manage CDSCO approval with proper documentation, application support, and regulatory guidance. CDSCO work requires accuracy, and professional support can reduce confusion, delay, and compliance risk.
Our team helps you understand the correct approval route, prepare documents, submit applications, respond to queries, and complete the process in a structured way.
Why Businesses Trust Diligence Certification
- Expert guidance for CDSCO drug approval and compliance
- Support in product classification and approval route selection
- Complete documentation and application assistance
- Help with CDSCO portal submission and query handling
- Transparent communication at every stage
- End-to-end support for manufacturers and importers
- Better chance of avoiding common application mistakes
- Time-saving process for pharma businesses
- Professional handling of technical and regulatory requirements
- Practical guidance for post-approval compliance
Conclusion
Important source of information for checking approved medicines and pharmaceutical products. It helps businesses understand whether a drug has received proper regulatory approval and supports safe, legal, and compliant market operations.
For pharmaceutical companies, CDSCO approval is not just a formality. It is a major step for product safety, market trust, and legal compliance. Whether you are planning to manufacture, import, or market a drug in India, proper approval and documentation are necessary.
Diligence Certification provides professional support for CDSCO approval, documentation, application filing, and compliance guidance. With expert assistance, businesses can avoid common mistakes and complete the approval process more smoothly.
Frequently Asked Questions
What is the CDSCO approved drugs list?
The CDSCO approved drugs list is an official record of drugs approved by the Central Drugs Standard Control Organisation for manufacture, import, marketing, or use in India.
Where can I check the list of approved drugs by CDSCO?
You can check it on the official CDSCO website under the approved new drugs, FDC, SND, vaccine, and other approval sections. CDSCO publishes year-wise approved new drug lists.
Is CDSCO approval mandatory for new drugs in India?
Yes, new drugs generally require approval from CDSCO before they can be manufactured, imported, marketed, or sold in India.
What details are available in the CDSCO approved drugs list?
The list may include drug name, indication, approval date, dosage form, applicant details, or other category-specific information.
What is the role of CDSCO in India?
CDSCO is India’s central drug regulatory authority responsible for approval and regulation of drugs, clinical trials, vaccines, biologicals, and other regulated healthcare products.
What is the difference between a new drug and an FDC?
A new drug is a drug that requires central approval due to its novelty, indication, dosage, or regulatory status. An FDC is a Fixed Dose Combination containing two or more active ingredients in a fixed ratio.
Can a company sell a drug without CDSCO approval?
If the drug requires CDSCO approval, it cannot be legally marketed without the required permission. Selling without approval may lead to legal action and business restrictions.
How long does CDSCO drug approval take?
The timeline depends on the drug category, document quality, technical data, CDSCO review, and query response. Complex products may take more time than simple applications.
Why do CDSCO applications get delayed?
Applications may get delayed due to wrong classification, incomplete documents, missing test reports, unclear technical data, incorrect forms, or late query responses.
How can Diligence Certification help with CDSCO approval?
Diligence Certification helps with product classification, document preparation, application filing, CDSCO portal support, query response, and complete regulatory guidance for drug approval in India.
